Overview

Saccharomyces Cerevisiae for Irritable Bowel Syndrome

Status:
Completed
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
This study is designed to see the response of saccharomyces cerevisiae for symptomatic improvement of patients with IBS
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Ziauddin University
Collaborator:
Hilton Pharma